Summit Securities Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Summit Securities Group's RGEN Position: Q2 2026 in Review
Summit Securities Group opened a new position in Repligen (RGEN) in Q2 2026: 400 shares worth $54.6K. The stake represents 0.01% of the portfolio and ranks #570 among its holdings. This is a return to the name: Summit Securities Group previously reported a position in RGEN as recently as Q1 2025.
Summit Securities Group first reported a position in RGEN in Q1 2025 and has held it in 2 quarters since. The position peaked at $165K in Q1 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Summit Securities Group held 400 shares of Repligen worth $54.6K as of Q2 2026.
- Repligen was a new Summit Securities Group position in Q2 2026.
- Repligen made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #570 holding.
- Summit Securities Group first reported a position in Repligen in Q1 2025 and has held it in 2 quarters since.
- Summit Securities Group's Repligen position peaked at $165K in Q1 2025.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.